DJIA 17,798.49 -14.90 -0.08%
NASDAQ 5,127.53 11.38 0.22%
S&P 500 2,090.11 1.24 0.06%
market minute promo

Johnson & Johnson (NYSE: JNJ)

company name or ticker
Company Photos
(Click to zoom)

Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for November 30, 2015

1 Dividend Stock to Rule Them All

Mirror, mirror, on the wall, what's the greatest dividend stock of them all?

Low Expense, Low Fuss, Income Growth

SPY Vs. Dividend Growth Portfolio

How Johnson & Johnson Spent $71 Billion in 12 Months

A slideshow reveals three interesting points about the pharmaceutical giant.

Arrowhead Research: Some Questions For Management

The Schwab U.S. Dividend Equity ETF Is Better Than Social Security

Johnson & Johnson's Latest FDA Approval Could Spell Problems for Amgen

Johnson & Johnson's newly approved multiple myeloma drug, Darzalex, is worth keeping an eye on for a number of reasons.

To Comfortably Beat The Market Dividend Growth Investors Should Consider CROIC

Gilead's (GILD) Cocktail HIV Drug Genvoya Approved in EU

See More Articles...